Frazier Financial Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-250
Closed -$2.81K 914
2024
Q2
$2.81K Sell
250
-50
-17% -$582 ﹤0.01% 748
2024
Q1
$3.72K Sell
300
-175
-37% -$2.28K ﹤0.01% 650
2023
Q4
$6.64K Buy
+475
New +$6.6K 0.01% 441

Other funds holding DVAX

Frazier Financial Advisors's DVAX Position: Q3 2024 in Review

Frazier Financial Advisors sold out of Dynavax Technologies (DVAX) in Q3 2024, closing a stake of 250 shares — an estimated $2.81K sold.

Frazier Financial Advisors first reported a position in DVAX in Q4 2023 and held it in 3 quarters. The position peaked at $6.64K in Q4 2023. 251 funds tracked by Wall St. Rank hold DVAX as of Q3 2024.

  • Frazier Financial Advisors reported no remaining Dynavax Technologies position as of Q3 2024 after selling out during the quarter.
  • Frazier Financial Advisors sold 250 Dynavax Technologies shares in Q3 2024, an estimated $2.81K.
  • Frazier Financial Advisors first reported a position in Dynavax Technologies in Q4 2023 and held it in 3 quarters.
  • Frazier Financial Advisors's Dynavax Technologies position peaked at $6.64K in Q4 2023.
  • 251 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2024.

Based on Frazier Financial Advisors's 13F filing for Q3 2024, filed 6 Nov 2024.